Warda, A.; Staniszewski, L.J.P.; Sabir, Z.; Livingston, S.; Sausedo, M.; Reshi, S.; Ron, E.; Applegate, M.T.; Haddad, D.; Khamisi, M.;
et al. Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas. Cells 2023, 12, 2575.
https://doi.org/10.3390/cells12212575
AMA Style
Warda A, Staniszewski LJP, Sabir Z, Livingston S, Sausedo M, Reshi S, Ron E, Applegate MT, Haddad D, Khamisi M,
et al. Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas. Cells. 2023; 12(21):2575.
https://doi.org/10.3390/cells12212575
Chicago/Turabian Style
Warda, Ankedo, Lech J. P. Staniszewski, Zhela Sabir, Sarah Livingston, Michael Sausedo, Sabeeha Reshi, Eyal Ron, Michael T. Applegate, Dena Haddad, Madleen Khamisi,
and et al. 2023. "Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas" Cells 12, no. 21: 2575.
https://doi.org/10.3390/cells12212575
APA Style
Warda, A., Staniszewski, L. J. P., Sabir, Z., Livingston, S., Sausedo, M., Reshi, S., Ron, E., Applegate, M. T., Haddad, D., Khamisi, M., Marshall, P. A., Wagner, C. E., & Jurutka, P. W.
(2023). Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas. Cells, 12(21), 2575.
https://doi.org/10.3390/cells12212575